Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2007
11/08/2007WO2007127216A2 Osmotic drug delivery system comprising release enhancing agent
11/08/2007WO2007127158A2 Modification of percutaneous absorption of topically active materials
11/08/2007WO2007126993A2 Multi-membrane immunoisolation system for cellular transplant
11/08/2007WO2007126851A2 Devices, systems and methods for medicament delivery
11/08/2007WO2007126777A2 Anti-microbial hand towel with time-delay chromatic transfer indicator and absorbency rate delay
11/08/2007WO2007126494A2 Coatings formed from stimulus-sensitive material
11/08/2007WO2007126322A1 A method for obtaining a pharmaceutical composition comprising an active agent ziprasidone or a pharmaceutically acceptable salt thereof
11/08/2007WO2007126136A2 Mask- tasting solid preparation of pioglitazone
11/08/2007WO2007126110A1 Method of producing polymer micelle having low molecular chemical encapsulated therein
11/08/2007WO2007126083A1 Method for stabilization of reduced coenzyme q10
11/08/2007WO2007126067A1 Nonaqueous pressure-sensitive adhesive composition, patches and process for production of patches
11/08/2007WO2007126063A1 Granulated particle, tablet and method for producing granulated particle
11/08/2007WO2007126048A1 Process for producing homogeneous and stable suspension and apparatus therefor
11/08/2007WO2007126039A1 Coated macrolide antibiotic preparation
11/08/2007WO2007125915A1 Solid matter containing coenzyme q
11/08/2007WO2007125888A1 Liquid composition for oral dosage
11/08/2007WO2007125731A1 Soft contact lens solution, drug-sustained release soft contact lens prepared by using the solution
11/08/2007WO2007125653A1 Oral liquid composition containing crude drug
11/08/2007WO2007125541A1 Pharmaceutical compositions of cefdinir
11/08/2007WO2007125455A1 Osmotic pump with at least one chargeable material
11/08/2007WO2007125339A1 Liquid oral compositions
11/08/2007WO2007125318A1 Non-aqueous liquid formulation for nasal or buccal administration
11/08/2007WO2007125295A2 Treatment of hypothyroidism
11/08/2007WO2007125217A1 Method for extemporaneous and reversible concentration of liposomes
11/08/2007WO2007125159A1 Surface modified aerosol particles, a method and apparatus for production thereof and powders and dispersions containing said particles
11/08/2007WO2007125134A1 Formulation of liposomal vesicles in aqueous solutions with tear film characteristics
11/08/2007WO2007125028A1 Method for solubilising hydrophobic active substances in an aqueous medium
11/08/2007WO2007124869A2 Liquid pharmaceutical formulation
11/08/2007WO2007124700A2 Pharmaceutical composition containing taxane derivative destined for the preparation of an infusion solution, method of preparation thereof and use thereof
11/08/2007WO2007124668A1 Pharmaceutical composition comprising high concentrate of polydatin
11/08/2007WO2007124618A1 Insulin-like growth factor-enriched nano-products of hairy antler and process for preparation thereof
11/08/2007WO2007124598A2 Softgel capsules with phytosterols and/or phytostanols and optionlly omega polyunstaurated fatty acids
11/08/2007WO2007124588A2 Colicinogenic strains of e. coli and use thereof for treatment of k88+-associated diarrhea
11/08/2007WO2007104732A3 Stable nanocapsule systems for the administration of active molecules
11/08/2007WO2007104549A3 Bioresorbable controlled-release composition
11/08/2007WO2007090822A3 Pharmaceutical formulation for aerosols, comprising two or more active agents and at least one surfactant
11/08/2007WO2007076462A3 Sublimable sustained release delivery system and method of making same
11/08/2007WO2007076274A3 Artificial tear solution containing poly (ethylene glycol) peg lipids
11/08/2007WO2007072491A3 Sustained release pharmaceutical formulation and treatment of ischemic heart disease by administering the same
11/08/2007WO2007062076A3 Dexrazoxane formulations and methods
11/08/2007WO2007060208A3 Fast-dissolving isotropic expanded microporous composition or structure for pharmaceutical, veterinary, dietetic, food or cosmetic use and method for obtaining same
11/08/2007WO2007051139A3 Diabetes management systems and methods
11/08/2007WO2007050512A3 Quick dissolving carrier granules
11/08/2007WO2007038801A3 Monovalent cation-binding compositions comprising core-shell particles having crosslinked poly-vinylic shells, and methods of use thereof
11/08/2007WO2007020085A3 Compositions containing taxane derivatives for intravenous injection
11/08/2007WO2006128469B1 Blends of inactive particles and active particles
11/08/2007WO2006093972A3 Particles
11/08/2007WO2005117755A3 Devices, systems and methods for treating sinusitius
11/08/2007WO2003013471A3 Pharmaceutical enteric coated composition comprising chitosan
11/08/2007US20070260174 Detecting a failure to maintain a regimen
11/08/2007US20070260038 Preparation of microparticles having improved flow ability
11/08/2007US20070259941 Ramipril formulation
11/08/2007US20070259834 Dermally Applicable Liquid Formulations for Controlling Parasitic Arthropods on Animals
11/08/2007US20070259810 Pharmaceutical compositions for lipophilic drugs
11/08/2007US20070259808 Comprising hydrolyzed gelatin, tryptophan and ingestible carrier; for decubitus ulcers/bariatric surgery; made up of the essential amino acids
11/08/2007US20070259383 Novel Genes involved in Epidermal differentiation, and uses thereof
11/08/2007US20070259372 Melanoma differentiation associated gene - 5 and promoter and uses thereof
11/08/2007US20070259334 Preservation of bioactive materials by spray drying
11/08/2007US20070259098 Water soluble, gelatin-free dip coatings for pharmaceutical solid dosage forms such as tablets comprising hydroxypropylmethyl cellulose and xanthan gum, carrageenan, and mixtures thereof, or hydroxypropylmethyl cellulose and castor oil or maltodextrin
11/08/2007US20070259049 Process for preparing lansoprazole
11/08/2007US20070259048 Mixture of micronized formoterol fumarate dihydrate salt (< 0.6 w/w) and a micronised pharmaceutically acceptable carrier/diluent, lactose; high storage stability such that the decomposition of formoterol will be < 2.0% (w/w) when stored in a powder device at 40 degrees C. and 75% relative humidity
11/08/2007US20070259047 Protein Sustained-Release Microparticle Preparation for Injection and Process for Producing the Same
11/08/2007US20070259046 Process for removal of solvents from bead polymers
11/08/2007US20070259045 Alcohol Resistant Dosage Forms
11/08/2007US20070259044 Compositions comprising biomembrane sealing agent for treatment of neuronal injury, and methods of use
11/08/2007US20070259043 Halide-free glucosamine-therapeutic drug salt compositions
11/08/2007US20070259041 Solid dosage formulations
11/08/2007US20070259040 Novel triptan formulations and methods for making them
11/08/2007US20070259039 Method for the treatment of acne
11/08/2007US20070259038 Solid Medicament Dosage Form Consumption Aid
11/08/2007US20070259037 Method and composition for treatment of inflammatory conditions
11/08/2007US20070259036 Lactic acid polymer and process for producing the same
11/08/2007US20070259035 Colored liquid-filled soft capsules and method of manufacture thereof
11/08/2007US20070259034 Highly absorbable coenzyme q10 composition and method of producing same
11/08/2007US20070259033 Controlled release formulations exhibiting an ascending rate of release
11/08/2007US20070259032 Method and use of nano-scale devices for reduction of tissue injury in ischemic and reperfusion injury
11/08/2007US20070259031 Central nervous system disorders such as cancer or neurodegenerative disorders; synthetic carrier such as liposome; Convection-enhanced delivery (CED) is a promising technique for local delivery of therapeutics that overcomes some of the limitations inherent in diffusion-based delivery
11/08/2007US20070259030 Methods, systems and reagents for tendon and ligament therapy
11/08/2007US20070259029 Water-dispersible patch containing an active agent for dermal delivery
11/08/2007US20070259027 Fentanyl suspension-based silicone adhesive formulations and devices for transdermal delivery of fentanyl
11/08/2007US20070259025 Absorbent antiviral structure
11/08/2007US20070259023 Insulin compensated nutrition
11/08/2007US20070259014 Compositions for and Methods for Treating Hiv
11/08/2007US20070259013 Pharmaceutical compositions comprising silica microspheres
11/08/2007US20070259010 Dosage forms and methods of use thereof
11/08/2007US20070259009 Aqueous Pharmaceutical Preparation Comprising Roflumilast
11/08/2007US20070259008 Polymalic Acid-Based Multi-Functional Drug Delivery System
11/08/2007US20070258994 Immunomodulatory formulations and methods for use thereof
11/08/2007US20070258939 Drug Delivery from Embolic Agents
11/08/2007US20070258926 Composition containing retinoic acid nanoparticles coated with inorganic salt of polyvalent metal
11/08/2007US20070258920 Process for obtaining polyphenol extracts from cocoa beans, the resulting extracts and uses thereof
11/08/2007US20070258910 Methods and devices for remineralization of hard tissues
11/08/2007US20070258909 Method for the Analysis of 1,1,1,2-Tetrafluoroethane
11/08/2007US20070258906 Methods and devices for detection and therapy of atheromatous plaque
11/08/2007US20070258894 System and Method for Real-Time Diagnosis, Treatment, and Therapeutic Drug Monitoring
11/08/2007US20070258890 Anthracycline Derivatives
11/08/2007US20070258889 Novel nanoparticles and use thereof
11/08/2007US20070256687 Enhanced Medical Product
11/08/2007US20070256685 Aerosol Formulations Comprising Formoterol Fumarate Dihydrate
11/08/2007DE202006020095U1 Dosierform enthaltend Oxycodon und Naloxon Dosage form comprising oxycodone and naloxone
1 ... 1340 1341 1342 1343 1344 1345 1346 1347 1348 1349 1350 1351 1352 1353 1354 1355 1356 1357 1358 1359 1360 ... 2991